A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Sponsor: Merck Sharp & Dohme LLC
Charleston, SC · +62 more sites
13 recruiting prostate cancer studies with a site in Charleston, SC.
Sponsor: Merck Sharp & Dohme LLC
Charleston, SC · +62 more sites
Sponsor: SWOG Cancer Research Network
Boiling Springs, SC · Charleston, SC · Greenville, SC · +331 more sites
Sponsor: PMV Pharmaceuticals, Inc
Charleston, SC · +31 more sites
Sponsor: Janssen Research & Development, LLC
Charleston, SC · Greer, SC · Myrtle Beach, SC · +51 more sites
Sponsor: VA Office of Research and Development
Charleston, SC · +16 more sites
Sponsor: Janux Therapeutics
Charleston, SC · Greenville, SC · +4 more sites
Sponsor: ECOG-ACRIN Cancer Research Group
Charleston, SC · +340 more sites
Sponsor: Canadian Cancer Trials Group
Charleston, SC · Rock Hill, SC · +372 more sites
Sponsor: Prostate Cancer Clinical Trials Consortium
Charleston, SC · Columbia, SC · +46 more sites
Sponsor: Medical University of South Carolina
Charleston, SC
Sponsor: Medical University of South Carolina
Charleston, SC
Sponsor: DualityBio Inc.
Charleston, SC · Greenville, SC · +26 more sites
Sponsor: Dendreon
Charleston, SC · Myrtle Beach, SC · +29 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.